Effects of Lateral Femoral Cutaneous Nerve Mobilization With and Without Muscle Energy Techniques on Neuropathic Pain, Knee Range of Motion and Quality of Life in Pregnant Females
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Meralgia Paresthetica
- Sponsor
- Riphah International University
- Enrollment
- 48
- Locations
- 2
- Primary Endpoint
- quality of life is assessed by QOL questioner
- Status
- Completed
- Last Updated
- 9 months ago
Overview
Brief Summary
The rationale of this study is to provide empirical evidence regarding the efficacy and safety of neural mobilization in pregnant women with meralgia paresthetica. By investigating the potential benefits of this intervention, healthcare professionals can make informed decisions about incorporating neural mobilization into the management of this condition during pregnancy. Focusing on the impact of neural mobilization and muscle energy techniques on both neuropathic pain and quality of life aligns with a patient-centered approach to care. The goal is not only to reduce symptoms but also to enhance overall well-being and functional capacity
Detailed Description
The literature gap of the study is that upto our knowledge, there is little or no evidence found in previous researches on the combined effects of lateral femoral cutaneous nerve mobilization in combination with MET in pregnant females. Secondly no quantitative measurement as range of motion with goniometer has been yet studied
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age ranges from 18 to 40 years
- •Body mass index ≥25kg/m
- •Pregnant females in third trimester diagnosed with myalgia paraesthetica.
- •Multigravida pregnant females
- •Patients will be screened through Prone Knee Bend (PKB) test for femoral nerve compression.
- •Positive pelvic compression test(1)
Exclusion Criteria
- •Those having other entrapment syndromes or radicular symptoms
- •Motor weakness
- •Having a history or ongoing cancerous proliferation
- •Active infection
Outcomes
Primary Outcomes
quality of life is assessed by QOL questioner
Time Frame: at base line pre intervention, at the end of 4th week post intervention
EQ-5D is used to measure quality of life
Knee range of motion is used to measure ROM
Time Frame: at base line pre intervention, at the end of 4th week post intervention
measured by goniometer
neuropathic pain
Time Frame: at base line pre intervention, at the end of 4th week post intervention
The Neuropathic Pain Scale (NPS) is a tool used to assess the specific qualities of pain associated with neuropathic pain. It helps differentiate neuropathic pain from other types of pain by evaluating different pain sensations and their intensity. The NPS consists of 10 items, each rated on a scale of 0 to 10, where 0 is "no pain" and 10 is the "worst imaginable pain".